CoChat

Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators

Open access
Leung, Stewart, Holbrook, April, King, Beverly, Lu, Hong-Tao, Evans, Vincent, Miyamoto, Neil, Mallari, Cornell, Harvey, Susan, Davey, Dave, Ho, Elena, Li, Wei-Wei, Parkinson, John, Horuk, Richard, Jaroch, Stefan, Berger, Markus, Skuballa, Werner, West, Christopher, Pulk, Rebecca, Phillips, Gary, Bryant, Judi, Subramanyam, Babu, Schaefer, Caralee, Salamon, Hugh, Lyons, Eric, Schilling, Daniela, Seidel, Henrik, Kraetzschmar, Joern, Snider, Michael, Perez, Daniel · 2005 · SLAS Discovery
Cited by 96

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The authors used the PatchXpress 7000A system to measure compound activity at the hERG channel using procedures that mimicked the "gold-standard" conventional whole-cell patch clamp. A set of 70 compounds, including hERG antagonists with potencies spanning 3 orders of magnitude, were tested on hERG302-HEK cells using protocols aimed at either identifying compound activity at a single concentration or obtaining compound potency from a cumulative concentration dependence paradigm. After exposure to compounds and subsequent washout of the wells to determine reversibility of the block, blockade by a reference compound served as a quality control. Electrical parameters and voltage dependence were similar to those obtained using a conventional whole-cell patch clamp. Rank order of compound potency was also comparable to that determined by conventional methods. One exception was flunarizine, a particularly lipophilic compound. The PatchXpress accurately identified the activity of 29 moderately potent antagonists, which only weakly displace radiolabeled astemizole and are false negatives in the binding assay. Finally, no false hits were observed from a collection of relatively inactive compounds. High-quality data acquisition by PatchXpress should help accelerate secondary screening for ion channel modulators and the drug discovery process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1087057104272295

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 96

Metadata

Authors
Leung, S., Holbrook, A., King, B., Lu, H.-T., Evans, V., Miyamoto, N., Mallari, C., Harvey, S., Davey, D., Ho, E., Li, W.-W., Parkinson, J., Horuk, R., Jaroch, S., Berger, M., Skuballa, W., West, C., Pulk, R., Phillips, G., Bryant, J., Subramanyam, B., Schaefer, C., Salamon, H., Lyons, E., Schilling, D., Seidel, H., Kraetzschmar, J., Snider, M., & Perez, D.
Venue
SLAS Discovery
Publisher
Elsevier BV
Published
2005-03
Volume
10
Issue
2
Pages
157-167
ISSN
2472-5552 (ISSN-L)
OpenAlex
W2102345870
Cited by
96
References
3
FWCI
3.80
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators. https://app.cochat.ai/papers/10.1177/1087057104272295
The paper
Leung, S., Holbrook, A., King, B., Lu, H.-T., Evans, V., Miyamoto, N., Mallari, C., Harvey, S., Davey, D., Ho, E., Li, W.-W., Parkinson, J., Horuk, R., Jaroch, S., Berger, M., Skuballa, W., West, C., Pulk, R., Phillips, G., . . . Perez, D. (2005). Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators. SLAS Discovery. https://doi.org/10.1177/1087057104272295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.